(Q50927490)

25 March 2018

title

Enhancement of tumor-associated antigen-specific T cell responses by radiofrequency ablation of hepatocellular carcinoma (English)

1 reference

25 March 2018

Hajime Sunagozaka

1 reference

25 March 2018

author name string

Eishiro Mizukoshi

1 reference

25 March 2018

Tatsuya Yamashita

1 reference

25 March 2018

Kuniaki Arai

1 reference

25 March 2018

Teruyuki Ueda

1 reference

25 March 2018

Fumitaka Arihara

1 reference

25 March 2018

Takashi Kagaya

1 reference

25 March 2018

Taro Yamashita

1 reference

25 March 2018

Kazumi Fushimi

1 reference

25 March 2018

Shuichi Kaneko

1 reference

25 March 2018

language of work or name

English

0 references

publication date

1 April 2013

1 reference

25 March 2018

published in

Hepatology

1 reference

25 March 2018

volume

1 reference

25 March 2018

issue

1 reference

25 March 2018

page(s)

1448-1457

1 reference

25 March 2018

Global cancer statistics, 2002

cites work

1 reference

Loco-regional treatment of hepatocellular carcinoma

21 January 2018

1 reference

Systematic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies

21 January 2018

1 reference

In situ tumor ablation creates an antigen source for the generation of antitumor immunity

21 January 2018

1 reference

Antitumor effect after radiofrequency ablation of murine hepatoma is augmented by an active variant of CC Chemokine ligand 3/macrophage inflammatory protein-1alpha.

21 January 2018

1 reference

Identification of alpha-fetoprotein-derived peptides recognized by cytotoxic T lymphocytes in HLA-A24+ patients with hepatocellular carcinoma

21 January 2018

1 reference

Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma

21 January 2018

1 reference

Expression of multidrug resistance-associated protein 3 and cytotoxic T cell responses in patients with hepatocellular carcinoma

21 January 2018

1 reference

Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma

21 January 2018

1 reference

Efficient identification of HLA-A*2402-restricted cytomegalovirus-specific CD8(+) T-cell epitopes by a computer algorithm and an enzyme-linked immunospot assay.

21 January 2018

1 reference

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

21 January 2018

1 reference

T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein

21 January 2018

1 reference

Identification of HLA-A2- or HLA-A24-restricted CTL epitopes possibly useful for glypican-3-specific immunotherapy of hepatocellular carcinoma

21 January 2018

1 reference

Comprehensive analysis of the alpha-fetoprotein-specific CD8+ T cell responses in patients with hepatocellular carcinoma.

21 January 2018

1 reference

cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3)

21 January 2018

1 reference

Identification of a gene coding for a new squamous cell carcinoma antigen recognized by the CTL

21 January 2018

1 reference

Localization of telomerase hTERT protein and hTR in benign mucosa, dysplasia, and squamous cell carcinoma of the cervix

21 January 2018

1 reference

A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells

21 January 2018

1 reference

Radiofrequency thermal ablation of hepatocellular carcinoma liver nodules can activate and enhance tumor-specific T-cell responses.

21 January 2018

1 reference

Cancer immunotherapy comes of age

21 January 2018

1 reference

Novel cancer immunotherapy agents with survival benefit: recent successes and next steps

21 January 2018

1 reference

Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Dynamic CT densitometry of hepatic tumors

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.26153

1 reference

25 March 2018

1 reference

25 March 2018